Celgene Corporation (CELG)

79.77 +0.33 (+0.415%)

IEX Real-Time Price

June 20, 2018 EST.

Nasdaq Global Select : Healthcare

Prev Close 79.44

Price Open 80

Volume: 6.71M

Avg Volume: 7.6M

Market Cap: 56.38B

P/E Ratio 11.49

52 Wk Range 74.13-147.17



CELG Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-05-31
703.13M
34.34M
4.31
4.88%

2018-05-15
721.15M
12.3M
2.02
1.71%

2018-04-30
721.15M
13.82M
2.33
1.92%

2018-04-13
748.5M
15.65M
2.09
2.09%




CELG Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-05-04
Q1 2018
BTO
1.78 (5)
1.61
-0.17

2018-04-26
Q1 2018
N/A
1.78 (5)
1.61
-0.17

2018-01-25
Q4 2017
N/A
1.75 (9)
1.61
-0.17

2017-10-26
Q3 2017
BTO
1.72 (8)
1.61
-0.17

News

Celgene Corporation Announces Appointment of Jonathan Biller as Executive Vice President and General Counsel Following the Departure of Gerald F. Masoudi (2018-06-19 16:30 Business Wire)

Celgene Corporation (NASDAQ:CELG) today announced the appointment of Jonathan Biller as Executive Vice President and General Counsel effective July 3, 2018. Mr. Biller will be responsible for global legal strategy and will serve on the company's Executive Committee. Mr. Biller will succe…

 


Statistics

Shares Outstanding: 706.84M

Top 15 Institution Percent: 66.50

Price To Sales: 4.06

Price To Book: 10.62

Revenue: 10.04B

Gross Profit: 9.69B

Cash: 33.94B

Debt: 28.56B

Return On Assets: 8.41

Return On Equity: 40.72

Profit Margin: 20.45

Price History

Beta: 1.42

50-day Moving Avg: 83.18

200-day Moving Avg: 102.66

YTD Change: -25.17

5-day Change: 2.66

1-month Change: 6.36

3-month Change: -10.27

6-month Change: -25.80

1-year Change: -36.53

Revenue Per Share: 14.00

Revenue Per Employee: 1344315.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Celgene Corporation

Exchange: Nasdaq Global Select

Industry: Biotechnology

Sector: Healthcare

Website: http://www.celgene.com

Celgene Corp is a biotech company that discovers, develops, and commercializes therapies designed to treat cancer and immune-inflammatory related diseases. Its registered brands are Abraxane, Istodax, Otezla, Pomalyst, Revlimid, Thalomid, Vidaza.